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AbstrACt
Objectives The goal of this study is to identify, analyse 
and classify interventions to improve adherence to 
reporting guidelines in order to obtain a wide picture 
of how the problem of enhancing the completeness of 
reporting of biomedical literature has been tackled so far.
Design Scoping review.
search strategy We searched the MEDLINE, EMBASE 
and Cochrane Library databases and conducted a grey 
literature search for (1) studies evaluating interventions 
to improve adherence to reporting guidelines in health 
research and (2) other types of references describing 
interventions that have been performed or suggested 
but never evaluated. The characteristics and effect of 
the evaluated interventions were analysed. Moreover, we 
explored the rationale of the interventions identified and 
determined the existing gaps in research on the evaluation 
of interventions to improve adherence to reporting 
guidelines.
results 109 references containing 31 interventions (11 
evaluated) were included. These were grouped into five 
categories: (1) training on the use of reporting guidelines, 
(2) improving understanding, (3) encouraging adherence, 
(4) checking adherence and providing feedback, and (5) 
involvement of experts. Additionally, we identified lack 
of evaluated interventions (1) on training on the use of 
reporting guidelines and improving their understanding, 
(2) at early stages of research and (3) after the final 
acceptance of the manuscript.
Conclusions This scoping review identified a wide range 
of strategies to improve adherence to reporting guidelines 
that can be taken by different stakeholders. Additional 
research is needed to assess the effectiveness of many of 
these interventions.
bACkgrOunD
Approximately 85% of all biomedical research 
today is estimated to be wasted, due, in part, 
to incomplete or inaccurate reporting.1 The 
past two decades have given rise to a number 
of changes in an effort to help authors and the 
broader scientific community properly report 
research methods and findings, which would 
allow them to contribute to the broader goal 
of combating waste in biomedical research. 
The most prominent of these changes has 
been the inception of reporting guidelines 
(RGs) for different study types, data and clin-
ical areas.2 
The vast majority of RGs have not yet been 
assessed as to whether they help improve the 
reporting of research,3 but some, such as the 
Consolidated Standards of Reporting Trials 
(CONSORT) for the reporting of randomised 
controlled trials (RCTs),4 have been shown to 
enhance the completeness of reporting.5 6
Dozens of systematic reviews have explored 
the extent of adherence to some RGs in 
certain areas of health research.7–10 Samaan 
et al11 went one step further and performed 
a systematic review of systematic reviews 
assessing adherence to RGs. As they consid-
ered a broad range of clinical areas and 
study designs, their results provided a global 
picture of adherence to RGs in health 
research. Although some studies reported 
acceptable overall levels of completeness of 
reporting and found that it had improved 
since the introduction of certain RGs such 
as CONSORT, the authors of most of the 
reviews (43 of 50, 86%) concluded that more 
improvement is needed or that adherence to 
RGs was inadequate, poor, medium or subop-
timal. Therefore, it is warranted to explore 
strengths and limitations of this study
 ► We considered a wide range of reporting guidelines 
as well as their extensions.
 ► Merging the evidence found in the published and 
grey literature allowed us to provide a broad picture 
of how the problem of enhancing adherence to re-
porting guidelines has been tackled so far and could 
be faced in the future.
 ► The screening and data extraction were performed 
in duplicate.
 ► We could have missed evidence of possible inter-
ventions that may not be present in the published or 
grey literature but are instead used in practice and 
continue to be used.
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and develop strategies to improve the current levels of 
adherence to RGs.
In recent years, several initiatives aiming to improve 
adherence to RGs have been proposed, some of which 
have already been evaluated. For example, the effect of 
journal endorsement of RGs3 5 6 and the implementation 
of writing aid tools for authors such as the CONSORT-
based web tool (COBWEB)12 have been assessed. While 
some of these strategies have not been shown to have a 
benefit,3 others report better but still suboptimal levels of 
reporting5 6 or even clear benefits.12 13
As mentioned, several reviews have analysed the quality 
of reporting in different clinical areas and for different 
study types.7–10 However, no scoping review has been 
performed that provides a global picture of different 
strategies aiming to improve adherence to RGs. Given the 
low levels of completeness of reporting in health research 
that have been observed,11 along with the imperative 
need to take further actions for mitigating this problem, 
we considered that performing such a scoping review was 
warranted.
In addition to analysing the implementation and effect 
of interventions that have already been evaluated, we 
aimed to gather other possible strategies that could be 
implemented and evaluated in the future.
For clarification, some relevant terms used throughout 
the scoping are defined in box 1, which is based on 
Stevens et al.3
MethODs
As presented in the published protocol,14 this scoping 
review follows the methodology manual published by the 
Joanna Briggs Institute for scoping reviews.15
Objectives
The scoping review questions are:
1. What interventions to improve adherence to RGs in 
health research have been evaluated?
2. What further interventions to improve adherence 
to RGs have been performed or suggested but never 
evaluated?
We aimed to analyse and classify the interventions 
found for both questions in order to obtain a wide picture 
of how the problem of adhering better to RGs has been 
tackled so far and can be tackled in the future.
eligibility criteria
We included:
1. Studies evaluating interventions aiming to improve 
adherence to RGs in health research, irrespective of 
study design.
2. Commentaries, editorials, letters, studies and online 
sources describing possible interventions to improve 
adherence to RGs that have been performed or sug-
gested but never evaluated.
The RGs considered were those shown on 8 May 2017 
on the Enhancing the QUAlity and Transparency Of 
Health Research (EQUATOR) Network website16 as ‘RGs 
for main study types’. In addition, we included Quality 
of Reporting of Meta-analyses, since it was the precursor 
of Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses (PRISMA). Online supplementary file 1 
shows all RGs considered.
We considered the following languages: English, 
Spanish, French, German and Catalan.
exclusion criteria
We have excluded references that include interventions 
that do not specifically aim to improve the complete-
ness of reporting, even though these interventions may 
actually influence completeness. For example, we have 
excluded clinical trial registration even though it may 
enhance the completeness of reporting, because its 
main goals are to improve clinical trial transparency 
while also reducing publication and selective reporting 
biases.
search strategy and study selection
On 8 May 2017, we searched PubMed, EMBASE and 
Cochrane Library databases for articles published 
between 1 January 1996 and 31 March 2017, in accor-
dance with our scheduled search.14 The detailed search 
terms for PubMed can be found in the protocol.
The retrieved studies were exported into Mendeley 
and duplicates were automatically removed using it. 
One reviewer (DB) first screened the titles and abstracts 
for eligibility. Each of the other two reviewers (JJK and 
EC) was randomly assigned 50% of the references and 
screened the titles and abstracts independently of the first 
reviewer. The reviewers classified the references into one 
of the following groups:
box 1 relevant definitions in the context of this scoping 
review
Adherence
Action(s) taken by authors to ensure that a research report is compli-
ant with the items recommended by the appropriate/relevant reporting 
guideline. These can take place before or after the first version of the 
manuscript is published.
endorsement
Action(s) taken by journals to indicate their support for the use of one 
or more reporting guideline(s) by authors submitting research reports 
for consideration.
Implementation
Action(s) taken by journals to ensure that authors adhere to an endorsed 
reporting guideline and that therefore published papers are completely 
reported.
Complete reporting
Pertains to the state of reporting of a study report and whether it is 
compliant with all the items recommended by the appropriate/relevant 
reporting guideline.
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A. Evaluated: Includes references describing interven-
tions to improve adherence to RGs that have been em-
pirically assessed.
B. Non-evaluated: Includes references describing inter-
ventions to improve adherence to RGs that have been 
performed or suggested but never evaluated.
C. Unclear: Includes references (1) containing vague 
statements such as ‘authors, editors and journals have 
to adhere better to RGs to improve the quality of re-
porting’ or ‘greater efforts have to be made by authors 
to check that their research is compliant with (the rel-
evant RG)’, or (2) not having the abstract available.
D. Excluded: Includes references (1) not describing in-
terventions to improve adherence to any of the RGs 
considered and (2) describing but not evaluating cer-
tain interventions that have already been classified as 
evaluated.
Disagreements were solved by discussion among the 
reviewers.
Second, one reviewer (DB) examined the full text of 
all group A and B references to confirm the previous clas-
sification, then all group C references to reclassify them 
either as group A, B or D. Reclassification was verified 
by the initial reviewer (JJK or EC). Finally, one reviewer 
(DB) ensured literature saturation by searching the refer-
ence lists of included studies, the lists of articles citing 
them according to PubMed, and the individual studies 
included in two relevant systematic reviews.3 6
In addition, we performed a grey literature search, 
which included: the websites of networks and organ-
isations promoting the use of RGs (ie, EQUATOR 
Network and National Library of Medicine Research 
Reporting Guidelines and Initiatives); work groups of 
medical journal editors (ie, International Committee 
of Medical Journal Editors and World Association of 
Medical Editors); biomedical journal publishers (ie, BMJ 
Publishing Group and BioMed Central); funding agencies 
(ie, National Institute of Health and European Research 
Council); online platforms of postpublication peer review 
(ie, PubPeer and ScienceOpen); and the abstract books 
of the past editions of the International Congress on Peer 
Review and Biomedical Publication.
Some of the included references were described in 
studies coauthored by some of the authors this scoping 
review. These references underwent the same process 
of screening, data extraction and data synthesis as the 
others.
Data extraction
A data extraction form was developed to collect the infor-
mation necessary for data synthesis. Two reviewers (DB, 
JJK) independently performed a pilot data extraction on 
a random sample of five articles and subsequently refined 
the form.
Extracted data included:
1. Publication characteristics: title, year of publication, 
author, author’s affiliation country and field of study.
2. Characteristics of the intervention:
a. Classification as evaluated or non-evaluated.
b. Research stage: education, grant writing, protocol 
writing, manuscript writing, submission, journal 
peer review, copyediting and postpublication.
c. Rationale of the intervention, which refers to the 
deduced reasons why the intervention is evaluated 
or proposed.
d. For evaluated interventions: details of the inter-
vention, study design (eg, RCT, before–after, etc), 
RGs considered and format (checklist, bullet points 
and/or examples), period of intervention, number 
of journals and articles involved, effect size of the in-
tervention on adherence to RGs and measure used 
to assess this effect.
3. Relevant conclusions.
Two reviewers (DB, JJK) independently performed data 
extraction for all studies except for the individual studies 
of the two systematic reviews evaluating journal endorse-
ment of RGs,3 6 since none of these studies described 
further interventions and their results had already 
been reported in these reviews. Discrepancies between 
reviewers were discussed and solved by consensus.
Data synthesis
Following data extraction, interventions to improve 
adherence to RGs were categorised as follows:
1. Training on the practical use of RGs: mentoring of dif-
ferent stakeholders on the practical use of RGs.
2. Enhancing accessibility and understanding: dissemina-
tion of RGs and the improvement of authors’ under-
standing of their content.
3. Encouraging adherence: suggestions and tools to facil-
itate compliance.
4. Checking adherence and providing feedback: check-
ing the level of compliance and indicating incorrect or 
missing items.
5. Involvement of experts: interaction and cooperation 
on methodology and reporting.
One reviewer (DB) performed the initial categori-
sation, which was verified and refined by the other two 
reviewers (JJK and EC).
Furthermore, we determined the existing gaps in 
research on the evaluation of interventions to improve 
adherence to RGs. More specifically, we identified which 
categories of interventions and which research stages 
have not been addressed so far in studies evaluating 
interventions.
We did not perform a meta-analysis of the observational 
studies assessing journal endorsement of RGs that were 
not included in the two systematic reviews previously 
mentioned.3 6 We considered that, for the purpose of this 
scoping review, these systematic reviews provided a reli-
able picture of the impact of this editorial intervention.
Deviations from the protocol
In order to better capture the most relevant aspects of 
the included studies, the original data extraction form 
proposed in the protocol was modified. We removed 
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the healthcare area of the studies included, refined the 
research stages considered and included more details on 
the implementation of the evaluated interventions.
Patients and public involvement
No patients or public were involved in the study.
results
The database search yielded 1399 citations after dedu-
plication (see figure 1). Screening of titles and abstracts 
resulted in a first classification, after which 435 papers were 
included for full-text review. We also reviewed the full text 
of 24 additional references found through forward citation 
searching. Furthermore, a grey literature search yielded 
seven additional references. Finally, 109 references were 
included. Some of these interventions appeared in more 
than one reference and some of the references contained 
more than one intervention. Ninety of these references 
(86 observational and 4 randomised studies) described 
11 evaluated interventions and the other 19 (12 research 
studies, 2 editorials, 2 blogs, 1 commentary, 1 essay and 
1 perspective) described 20 non-evaluated interventions. 
Figure 2 displays these 31 interventions according to their 
categorisation and the research stage where they can be 
performed. Moreover, table 1 shows all interventions in a 
tabular format together with their rationale. All interven-
tions reported in this section were found in the literature 
and do not necessarily correspond to the personal ideas 
of the scoping review authors.
Among the 11 evaluated interventions identified, we 
found a variety of measures used to assess their effect on 
adherence to RGs, including:
 ► Score for completeness of reporting for each paper, 
either assigning different or equal weights to RG 
items, on a 0–10 scale.
 ► Percentage of items reported for each paper.
Figure 1 PRISMA flow diagram. PRISMA,  Preferred Reporting Items for Systematic Reviews and Meta-Analyses.
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 ► Percentage of compliance per RG item.
 ► Score for the Manuscript Quality Assessment Instru-
ment17 for each paper.
Due to the heterogeneity of these measures and for the 
sake of clarity, we prefer to omit the information on the 
exact effect sizes in the main body of the manuscript and 
show it in online supplementary file 2, together with the 
implementation details of the evaluated interventions. 
In this way, these effects can be understood in an appro-
priate context.
Research gaps identified (see figure 3) included the 
evaluation of interventions (1) on training on the use of 
RGs and improving understanding of these, (2) at early 
stages of research (education, grant writing or protocol 
writing) and (3) after the final acceptance of the manu-
script (copyediting or postpublication peer review).
Hereafter, we describe the interventions found for 
each category (table 1 and online supplementary file 2 
summarise these interventions).
training on the practical use of rgs
Four non-evaluated interventions related to educating 
different stakeholders on the practical use of RGs were 
found.18–23
In a first step, health profession schools could incorpo-
rate RGs into curricula that address research methodology 
and publication standards.18–22 In line with this, students 
could develop protocols for coursework and research 
using RGs such as Standard Protocol Items: Recommen-
dations for Interventional Trials (randomised trials) and 
PRISMA-Protocol (systematic reviews), and educators 
may encourage adherence to those guidelines and grade 
the protocols using them.21 For their part, funders may 
consider supporting author training on RGs.23 Finally, 
journals or publishers may consider investing resources 
in training editors and reviewers on the content and use 
of RGs.22 23
enhancing accessibility and understanding
We identified three non-evaluated interventions focused 
on increasing the awareness of the existence of RGs, 
as well as the authors’ understanding of the content of 
these.24–26
First, international scientific associations may play 
an important role in disseminating and popularising 
RGs to large audiences.24 Second, RG developers might 
consider translating them to new languages that have not 
been addressed yet.25 Finally, further databases of exam-
ples of good reporting for different RGs that are acces-
sible to authors can be developed, as has been done for 
CONSORT.26
encouraging adherence
Fourteen interventions found were associated with 
different strategies to facilitate compliance with 
RGs.11 12 21 27–115 Six of these were evaluated.12 27–107 113
Funders might require authors to use RGs as a template 
for grant application proposals.21 Later on, research 
ethics boards may require that protocols submitted for 
ethical approval clearly state which RGs the study will be 
using based on the study design, and that RG checklists 
are part of the application for ethics approval.11 Funders 
Figure 2 Typology of interventions to improve adherence to RGs according to type of intervention and research stage. 
Evaluated interventions are shown in bold. CONSORT, Consolidated Standards of Reporting Trials; RGs, reporting guidelines. 
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Table 1 Rationale of the interventions identified.
Group Intervention Rationale
Training on the 
practical use of 
RGs
Introduction of RGs and journalology into graduate 
curricula18–22
To introduce good research reporting habits early in young 
researchers’ scientific careers.
Student’s development of protocols for coursework and 
research using RGs21
Funder’s support of author training on RGs23 Authors, editors and peer reviewers have insufficient training in 
issues related to reporting.Training for peer reviewers and editors on RGs by 
journals22 23
Enhancing 
accessibility 
and 
understanding
Dissemination of RGs by scientific associations24 A large number of researchers are not aware of the existence of 
RGs.
Translation of RGs to further languages25 Language barriers may affect the proper use of RGs.
Development of expanded database of examples for each 
RG26
Authors need more examples of good reporting to properly 
understand certain items.
Encouraging 
adherence
Author use of RGs as a template for grant application 
proposals21
Using RGs in early stages may facilitate completeness of 
reporting of published research.
Required checklist for ethics approval application11
Funder’s requirement of checklists in author’s report21 108
Author use of the writing aid tool COBWEB12 (A) Authors need help to successfully adhere to RGs at the 
writing stage and (B) Dividing RG items into bullet points and 
providing examples might help.
Author use of a structured approach for reporting 
research47 112
(A) To help authors avoid omissions, (B) to aid reviewers and 
editors in appraising articles and (C) to allow more efficient data 
extraction during the systematic review process.Author mark-up of the manuscript to indicate where each 
RG item is addressed109
Editorial statement endorsing certain RGs27–46 48–106 113 Authors read editorial statements and follow ‘Instructions to 
authors’.Recommendation or requirement to follow RGs in the 
‘Instructions to authors’27–46 48–106 113
Requirement to submit an RG checklist together with the 
manuscript indicating page numbers corresponding to each 
item27–46 48–106 113
Authors may not consider editorial statements or 
recommendations in ‘Instructions to authors’ to be important. 
Compulsory submission of checklists or text mark-up may 
encourage authors to be more compliant with RGs.Requirement to populate and submit an RG checklist with 
text from the manuscript114
Journal development of core versions of RGs containing 
key items110
Focusing on the most important items could be more effective 
than considering the whole checklist.
Guidance to authors on manuscript preparation by 
publication officers111
Trained journal officers may enhance authors’ compliance with 
RGs during manuscript preparation.
Suggestion for peer reviewers to use RGs107 Peer reviewers often do not detect reporting flaws. Therefore, 
they may need to follow a more systematic approach and use 
RGs.
Editor’s questions to peer reviewers about whether the 
authors have followed RGs115
Checking 
adherence 
and providing 
feedback
Completeness of reporting check by editors117 Requiring checklists at submission does not guarantee 
adherence. Editors and peer reviewers have to check whether 
submitted papers are compliant with RGs.
Peer review against RGs118
Internal peer review against RGs by a trained editorial 
assistant120
It is extremely unlikely that the average clinical peer reviewer 
has the methodological expertise to check a paper against RGs.
Implementation of the automatic tool Statreviewer121
Email to authors to revise the manuscript according to 
RGs13
It might be more effective to ask authors for adherence to RGs 
during the revision process because they will do anything to get 
their paper published.Implementation of the tool WebCONSORT119
Completeness of reporting check at copyediting122 Copyediting and postpublication offer alternate time points to 
improve adherence to RGs.Postpublication peer review123
Involvement of 
experts
Statistician involvement (78 128–130) Professionals with specific knowledge of RGs might help 
authors when designing, conducting or reporting their research.
Medical writer involvement.108
COBWEB, CONSORT-based web tool; CONSORT, Consolidated Standards of Reporting Trials.
RGs, reporting guidelines.
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could also encourage adherence to RGs by asking for RG 
checklists as part of the authors’ report.21 108
One initiative to support authors adhering to RGs at 
the writing stage of the manuscript has been COBWEB, 
a writing aid tool that aims to help authors adequately 
combine the different extensions of the CONSORT 
statement.12 This tool divided the CONSORT items into 
bullet points showing the key elements that need to be 
reported together with examples of adequate reporting. 
The impact of COBWEB was evaluated in a randomised 
trial that showed a large effect of this intervention12 
(see online supplementary file 2 for more details about 
this and other evaluated interventions). A second option 
to support authors at manuscript writing is that they 
follow a more structured approach. For example,  Clini-
calTrials. gov requires authors to report key information 
in a tabular format when registering a study or making 
available its results.116 This has been shown to be effective: 
some results posted on this platform, especially harms, 
are more complete than those in corresponding journal 
articles reporting the same trials.47 Another possibility to 
improve the structure of manuscripts is to include new 
subheadings corresponding to different RG items within 
the traditional format introduction, methods, results and 
discussion, as the American Journal of Orthodontics and 
Dentofacial Orthopedics (AJO-DO) proposed.112 Finally, 
authors may also avoid omissions when writing the 
manuscript if mark-up the text and highlight where each 
item of the relevant checklist is addressed.109
At the manuscript submission stage, different editorial 
actions have been taken to improve adherence to RGs. 
The most popular is what has traditionally been defined 
as journal endorsement of RGs, which is usually defined 
as one or more of the three following interventions: (1) 
journal editorial statement endorsing certain RGs; (2) 
requirement or recommendation in journal’s ‘Instruc-
tions to Authors’ to follow certain RGs when preparing 
their manuscript or (3) requirement for authors to submit 
the appropriate RG checklist together with their manu-
script indicating page numbers corresponding to each 
item.6 Dozens of observational studies have explored the 
possible effect of journal endorsement of different RGs 
in different clinical areas.27–46 48–106 113 A recent systematic 
review focused on CONSORT evaluations showed rela-
tive but suboptimal improvements in the completeness 
of reporting in journals by following the aforementioned 
policies,6 while another systematic review considering 
nine other guidelines showed no improvements.3
Journals might also consider other strategies to enhance 
adherence to RGs at submission. A first option could 
be to develop shorter, core versions of RGs containing 
key items, which could be provided to authors as part 
of the submission process.110 Second, they might intro-
duce publication officers in order to provide guidance 
Figure 3 Gaps in research on the evaluation of interventions to improve adherence to RGs. Each circle represents one 
intervention. Variables displayed: (1) Circle size: number of studies evaluating each intervention (bigger=more studies); 
(2) Circle colour: study design of those studies (blue for RCTs and green for observational studies) and (3) Circle fill: kind 
of RG implementation (plain for checklist and stripes for bullet points and examples). Research gaps are highlighted in 
red. RCTs, randomised controlled trials; RGs, reporting guidelines.
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to authors on preparing manuscripts for submission.111 
Third, editors may ask authors to populate the relevant 
checklist with text from their manuscript and not accept 
a submission unless this is provided.114
Finally, editors may suggest that peer reviewers use 
RGs.107 In addition, by asking peer reviewers questions 
about whether the author has followed RGs, this might be 
an indirect way to encourage them.115
Checking adherence and providing feedback
Eight interventions were related to monitoring level of 
compliance with RGs of the manuscripts and providing 
instructions to authors on how to improve the reporting 
of missing or incorrect items.13 117–123 Four of them were 
evaluated.13 117–119
Some journals have opted for implementing RGs at 
peer review. First, an associate editor may assess manu-
scripts for adherence to the relevant RG and ask authors 
to make changes accordingly.117 This process may be 
repeated until the associate editor thinks that the manu-
script can move to the next step of the review process, 
leading to an editorial decision. This intervention was 
evaluated at the AJO-DO and showed satisfactory results: 
33 of 37 items reached perfect compliance.117 Second, 
peer reviewers could also assess the manuscripts against 
the appropriate checklist.118 While the observed effect 
of this intervention was slightly positive, it was smaller 
than hypothesised. In fact, investigators pointed out that 
authors tended to comply better with suggestions coming 
from standard reviews rather than from reviews against 
RGs, implying that it might be difficult to adhere to high 
methodological standards at late stages of research if 
these standards are not considered earlier in the research 
process. Third, journals could also ask trained editorial 
assistants to check manuscripts against RGs120 or to imple-
ment automatic peer-review tools such as StatReviewer,124 
software that automatically checks adherence to RGs and 
evaluates the appropriate use and reporting of statis-
tical tests.121 Currently, its performance is being assessed 
through a pilot trial in collaboration with four BioMed 
Central Journals.121 In any of those cases, emails could 
be sent to authors asking them to revise the manuscript 
according to guidelines.13 To do this, the EQUATOR 
network has provided standard letters that can be used 
(1) after checks by an editor or a single peer reviewer, 
(2) after full peer review or (3) alongside acceptance.125 
Furthermore, at the time of author revision of the manu-
script, Hopewell et al found no significant effect when 
incorporating WebCONSORT, a web-based tool that 
generates a unique list of items customised to the trial 
design, to the revision process of journals that endorsed 
CONSORT but had no active policy for implementing 
it.119 Finally, in a late stage of the publication process, 
copyediting of the manuscript could also ensure that all 
items are covered.122
Once the paper is published, the scientific commu-
nity could use online platforms of postpublication peer 
review such as PubPeer126 or ScienceOpen127 to evaluate 
the adherence to RGs of published articles and to provide 
feedback to authors.123
Involvement of experts
Two interventions identified implied interaction and 
cooperation between authors and experts on methodology 
and reporting at different stages of research.78 108 128–130 
One of them was evaluated.78 128–130
On the one hand, statisticians (or epidemiologists or 
other quantitative methodologists) may get involved 
in the design, conduct or reporting of the study might 
contribute to properly reporting key areas such as sample 
size calculation, randomisation, blinding and appropriate 
statistical analysis.129 While three studies found a statisti-
cally significant positive relationship between CONSORT 
scores and statistician involvement,78 129 130 another one 
did not.128 On the other hand, it has been hypothe-
sised that the involvement of medical writers during the 
manuscript writing stage of research could improve the 
completeness of reporting.108
Interventions described in papers coauthored by authors of 
this scoping review
Twenty-five (of 109) included references describing 
21 (of 31) included interventions were coau-
thored by at least one of the authors of this scoping 
review.12 13 20–23 26 47 54 55 63 67 74 76 80 104 107 111 114 115 117–120 123
DIsCussIOn
In this scoping review, we identified 31 interventions to 
improve adherence to RGs. We have also determined the 
gaps in research on the evaluation of this type of inter-
ventions. By considering a wide range of RGs as well as 
their extensions and merging the evidence found in 
the published and grey literature, this review provides a 
broad picture of how the problem of enhancing adher-
ence to RGs has been tackled so far and could be faced 
in the future.
This study reveals that most published research aimed 
at improving adherence to RGs has been conducted in 
journals. Typically, journal strategies range from making 
available editorial statements that endorse certain RGs, 
recommending or requiring authors to follow RGs in the 
‘Instructions to authors’, and requiring authors to submit 
an RG checklist together with the manuscript, with page 
numbers indicated for each item. However, these strate-
gies have been shown not to have the desired effect.3 6 131 
Recent research has called for more active and enforced 
journal policies throughout the editorial process, such 
as requiring the use of structured approaches with 
new subheadings adapted to different kinds of study 
designs,112 which was also found to be beneficial in a new 
study outside of our search period132; providing guidance 
on manuscript preparation111; making sure the peer-re-
view process involves editorial assistants who have specific 
training on reporting issues120 and implementing auto-
matic peer-review tools.121 Journals will vary in their ability 
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to make some of these strategies effective, depending on 
factors such as their resources, their guidelines to peer 
reviewers and the dedication of their editors—many 
editors and editorial staff work part time and have a 
limited amount of time.
Moreover, editors’ education and performance should 
be improved. A recent study pointed out that more 
than one-third (39%) of the manuscripts classified as 
randomised trials by the editorial staff were not actually 
randomised trials.119 133 Consequently, it seems difficult to 
improve author and peer reviewer adherence to RGs if 
journal gatekeepers are not properly trained in method-
ological and reporting issues.
Apart from journals, editors and peer reviewers, other 
key stakeholders such as medical schools, research funders, 
universities and other research institutions should also 
take responsibility regarding this issue. This scoping 
review provides some strategies to follow. However, as the 
problem is complex and the possible interventions are 
varied, enhancing the completeness of reporting most 
likely depends not so much on any isolated action but on 
a set of strategies by several different stakeholders. These 
could be enacted at different stages of research, from 
education to article postpublication.
For interventions aiming to improve adherence to 
RGs, we should require the same level of evidence that 
we require for interventions to improve health. For this 
reason, it is striking that we found only four published 
randomised trials that evaluated interventions to improve 
adherence to RGs.12 107 118 119 Among these trials, statis-
tically significant effect of the intervention was only 
observed for the use of the writing aid tool for authors 
COBWEB.12 While performing an additional review 
against RGs showed slightly positive but not significant 
effect,118 suggesting the use of RGs to peer reviewers107 
or implementing at the process of author revision of the 
manuscript the web-based tool WebCONSORT showed 
no benefit.119 The rest of the evaluations of interventions 
found (86 of 90) were observational studies, whose results 
are subject to the influence of confounding factors. As 
already mentioned, the impact of journal endorsement 
on completeness of reporting was suboptimal.3 6 However, 
completeness of reporting improved remarkably when 
RGs were actively implemented by editors (eg, if editors 
perform a completeness of reporting check of the manu-
script117) and when research results were posted in a 
tabular format without discussion or conclusions.47 Future 
randomised trials should consider evaluating these inter-
ventions or addressing some of the research gaps identi-
fied in this review, such as improving adherence to RGs at 
the grant application or protocol writing stages.
A few of the interventions found in this review were 
shown to enhance adherence to RGs. However, it is note-
worthy there is no evidence that some successful inter-
ventions12 117 have been implemented more widely later. 
For this reason, more resources and efforts are needed to 
further implement these interventions in other settings, 
evaluate the effect, and share the results with the scientific 
community. In any case, it is important to keep in mind 
that contemporary publication culture may harm the 
potential improvements in reporting quality. This could 
result from the fact that most scientists feel that the 
primary evaluation tool of their research is the quantity 
of their scientific output rather than its quality134; and 
such attitudes may undermine the potential effect of any 
intervention to improve adherence to RGs.
Our scoping review has some limitations. First, we did 
not formally assess the methodological quality of the 
studies that evaluated interventions. Second, restricting 
to certain databases or not having standard search terms 
for the databases searched may have excluded relevant 
publications. Third, it is possible that we could have 
missed evidence of possible interventions that may have 
never been reflected in the published or grey literature 
but are instead used in practice and continue to be used. 
For example, journals might be applying specific editorial 
strategies that are not publicly available on their websites 
or in the published literature.
COnClusIOn
Improving adherence to RGs is one of the key issues in 
order to enhance complete and accurate reporting and 
therefore reduce waste in research.
Different stakeholders—such as research funders, 
ethics boards and journals—should consider imple-
menting and evaluating some of the interventions iden-
tified in this study.
Acknowledgements The authors thank the MiRoR Project (http:// miror- ejd. eu/) 
and Marie Sklodowska-Curie Actions for their support. The authors also thank Matt 
Elmore for editorial help. This review is part of a larger project whose next goals are 
(1) to capture editors’ perceptions on the barriers and facilitators of some promising 
interventions identified in this review, (2) to explore new possible interventions and 
(3) to evaluate one of these interventions in collaboration with BMJ Open. 
Contributors All authors contributed to conceptualising and designing the study. 
DB, EC and JJK independently performed screening. DB and JJK independently 
performed data extraction. DB performed initial data synthesis and EC, IB, DM, 
DA and JJK refined it. DB drafted the manuscript. EC, IB, DM, DA and JJK made 
major revisions. Due to the strong involvement of JJK and EC at several different 
stages of the study, all authors agreed to consider them joint senior authors of the 
scoping review, although EC was the only senior author of the protocol. All authors 
read and approved the final manuscript, which was completed in April 2018. DA 
passed away in June 2018 and therefore could not approve the revised manuscript 
(November 2018).
Funding This scoping review belongs to the ESR 14 research project from the 
Methods in Research on Research (MiRoR) project (http:// miror- ejd. eu/), which has 
received funding from the European Union’s Horizon 2020 research and innovation 
programme under the Marie Sklodowska-Curie grant agreement No 676207. DM is 
supported through a University Research Chair (University of Ottawa).
Competing interests DA and DM are directors of the UK and Canadian EQUATOR 
Centres, respectively. IB is deputy director of French EQUATOR Centre. 
Patient consent for publication Not required.
Provenance and peer review Not commissioned; externally peer reviewed.
Data sharing statement The datasets used and/or analysed during the current 
study are available from the corresponding author on reasonable request.
Open access This is an open access article distributed in accordance with the 
Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits 
others to copy, redistribute, remix, transform and build upon this work for any 
purpose, provided the original work is properly cited, a link to the licence is given, 
 o
n
 10 M
ay 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026589 on 9 May 2019. Downloaded from 
10 Blanco D, et al. BMJ Open 2019;9:e026589. doi:10.1136/bmjopen-2018-026589
Open access 
and indication of whether changes were made. See: https:// creativecommons. org/ 
licenses/ by/ 4. 0/.
reFerenCes
 1. Chalmers I, Glasziou P. Avoidable waste in the production and 
reporting of research evidence. Lancet 2009;374:86–9.
 2. EQUATOR Network. Library for health research reporting. http://
www. equator- network. org/ resource- centre/ library- of- health- 
research- reporting.
 3. Stevens A, Shamseer L, Weinstein E, et al. Relation of 
completeness of reporting of health research to journals' 
endorsement of reporting guidelines: systematic review. BMJ 
2014;348:g3804.
 4. Schulz KF, Altman DG, Moher D. CONSORT Group. CONSORT 
2010 statement: updated guidelines for reporting parallel group 
randomised trials. BMJ 2010;340:c332.
 5. Plint AC, Moher D, Morrison A, et al. Does the CONSORT checklist 
improve the quality of reports of randomised controlled trials? A 
systematic review. Med J Aust 2006;185:263–7.
 6. Turner L, Shamseer L, Altman DG, et al. Does use of the CONSORT 
Statement impact the completeness of reporting of randomised 
controlled trials published in medical journals? A Cochrane review. 
Syst Rev 2012;1:60.
 7. Bereza BG, Machado M, Einarson TR, et al. Assessing the reporting 
and scientific quality of meta-analyses of randomized controlled 
trials of treatments for anxiety disorders. Ann Pharmacother 
2008;42:1402–9.
 8. Fung AE, Palanki R, Bakri SJ, et al. Applying the CONSORT and 
STROBE statements to evaluate the reporting quality of neovascular 
age-related macular degeneration studies. Ophthalmology 
2009;116:286–96.
 9. Rios LP, Odueyungbo A, Moitri MO, et al. Quality of reporting of 
randomized controlled trials in general endocrinology literature. J 
Clin Endocrinol Metab 2008;93:3810–6.
 10. Shea B, Bouter LM, Grimshaw JM, et al. Scope for improvement in 
the quality of reporting of systematic reviews. From the Cochrane 
Musculoskeletal Group. J Rheumatol 2006;33:9–15.
 11. Samaan Z, Mbuagbaw L, Kosa D, et al. A systematic scoping 
review of adherence to reporting guidelines in health care literature. 
J Multidiscip Healthc 2013;6:169–88.
 12. Barnes C, Boutron I, Giraudeau B, et al. Impact of an online 
writing aid tool for writing a randomized trial report: the COBWEB 
(Consort-based WEB tool) randomized controlled trial. BMC Med 
2015;13:221.
 13. Hopewell S, Ravaud P, Baron G, et al. Effect of editors’ 
implementation of CONSORT guidelines on the reporting of 
abstracts in high impact medical journals: interrupted time series 
analysis. BMJ 2012;344:e4178.
 14. Blanco D, Kirkham JJ, Altman DG, et al. Interventions to improve 
adherence to reporting guidelines in health research: a scoping 
review protocol. BMJ Open 2017;7:e017551.
 15. . Reviewers’ Manual. 2015; Available from: www. joannabriggs. org
 16. . EQUATOR Network. Available from: http://www. equator- network. 
org/
 17. Goodman SN, Berlin J, Fletcher SW, et al. Manuscript quality before 
and after peer review and editing at Annals of Internal Medicine. 
Ann Intern Med 1994;121:11–21.
 18. Ma B, Qi GQ, Lin XT, et al. Epidemiology, quality, and reporting 
characteristics of systematic reviews of acupuncture interventions 
published in Chinese journals. J Altern Complement Med 
2012;18:813–7.
 19. Larson EL, Cortazal M. Publication guidelines need widespread 
adoption. J Clin Epidemiol 2012;65:239–46.
 20. Sarkis-Onofre R, Cenci MS, Moher D, et al. Research reporting 
guidelines in dentistry: A survey of editors. Braz Dent J 2017;28:3–8.
 21. Shamseer L, Moher D, Clarke M, et al. the PRISMA-P Group. 
Preferred reporting items for systematic review and meta-analysis 
protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 
2015;349:g7647.
 22. Simera I, Moher D, Hirst A, et al. Transparent and accurate reporting 
increases reliability, utility, and impact of your research: reporting 
guidelines and the EQUATOR Network. BMC Med 2010;8:24.
 23. Glasziou P, Altman DG, Bossuyt P, et al. Reducing waste from 
incomplete or unusable reports of biomedical research. Lancet 
2014;383:267–76.
 24. Verbeek J. Moose Consort Strobe and Miame Stard Remark or 
how can we improve the quality of reporting studies. Scand J Work 
Environ Health 2008;34:165–7.
 25. Kim KH, Kang JW, Lee MS, et al. Assessment of the quality of 
reporting in randomised controlled trials of acupuncture in the 
Korean literature using the CONSORT statement and STRICTA 
guidelines. BMJ Open 2014;4:e005068.
 26. Moher D, Hopewell S, Schulz KF, et al. Resources for authors of 
reports of randomized trials: harnessing the wisdom of authors, 
editors, and readers. Trials2011;12:98.
 27. Faunce TA, Buckley NA. Of consents and CONSORTs: reporting 
ethics, law, and human rights in RCTs involving monitored overdose 
of healthy volunteers pre and post the "CONSORT" guidelines. J 
Toxicol Clin Toxicol 2003;41:93–9.
 28. Halpern SH, Darani R, Douglas MJ, et al. Compliance with the 
CONSORT checklist in obstetric anaesthesia randomised controlled 
trials. Int J Obstet Anesth 2004;13:207–14.
 29. Hewitt C, Hahn S, Torgerson DJ, et al. Adequacy and reporting of 
allocation concealment: review of recent trials published in four 
general medical journals. BMJ 2005;330:1057–8.
 30. Greenfield ML, Rosenberg AL, O'Reilly M, et al. The quality of 
randomized controlled trials in major anesthesiology journals. 
Anesth Analg 2005;100:1759–64.
 31. Llorca J, Martínez-Sanz F, Prieto-Salceda D, et al. Quality of 
controlled clinical trials on glaucoma and intraocular high pressure. 
J Glaucoma 2005;14:190–5.
 32. Haahr MT, Hróbjartsson A. Who is blinded in randomized clinical 
trials? A study of 200 trials and a survey of authors. Clin Trials 
2006;3:360–5.
 33. Kober T, Trelle S, Engert A. Reporting of randomized controlled 
trials in Hodgkin lymphoma in biomedical journals. J Natl Cancer 
Inst 2006;98:620–5.
 34. Biondi-Zoccai GG, Lotrionte M, Abbate A, et al. Compliance with 
QUOROM and quality of reporting of overlapping meta-analyses on 
the role of acetylcysteine in the prevention of contrast associated 
nephropathy: case study. BMJ 2006;332:202–9.
 35. Balasubramanian SP, Wiener M, Alshameeri Z, et al. Standards of 
reporting of randomized controlled trials in general surgery: can we 
do better? Ann Surg 2006;244:663–7.
 36. Dias S, McNamee R, Vail A, et al. Evidence of improving quality of 
reporting of randomized controlled trials in subfertility. Hum Reprod 
2006;21:2617–27.
 37. Smidt N, Rutjes AW, van der Windt DA, et al. The quality of 
diagnostic accuracy studies since the STARD statement: has it 
improved? Neurology 2006;67:792–7.
 38. Coppus SF, van der Veen F, Bossuyt PM, et al. Quality of reporting 
of test accuracy studies in reproductive medicine: impact of the 
Standards for Reporting of Diagnostic Accuracy (STARD) initiative. 
Fertil Steril 2006;86:1321–9.
 39. Tiruvoipati R, Balasubramanian SP, Atturu G, et al. Improving 
the quality of reporting randomized controlled trials in 
cardiothoracic surgery: the way forward. J Thorac Cardiovasc Surg 
2006;132:233–40.
 40. Mahoney J, Ellison J. Assessing the quality of glucose monitor 
studies: a critical evaluation of published reports. Clin Chem 
2007;53:1122–8.
 41. Poolman RW, Abouali JA, Conter HJ, et al. Overlapping systematic 
reviews of anterior cruciate ligament reconstruction comparing 
hamstring autograft with bone-patellar tendon-bone autograft: why 
are they different? J Bone Joint Surg Am 2007;89:1542–52.
 42. Spring B, Pagoto S, Knatterud G, et al. Examination of the analytic 
quality of behavioral health randomized clinical trials. J Clin Psychol 
2007;63:53–71.
 43. Agha R, Cooper D, Muir G. The reporting quality of randomised 
controlled trials in surgery: a systematic review. Int J Surg 
2007;5:413–22.
 44. Kane RL, Wang J, Garrard J. Reporting in randomized clinical 
trials improved after adoption of the CONSORT statement. J Clin 
Epidemiol 2007;60:241–9.
 45. Paranjothy B, Shunmugam M, Azuara-Blanco A, et al. The quality 
of reporting of diagnostic accuracy studies in glaucoma using 
scanning laser polarimetry. J Glaucoma 2007;16:670–5.
 46. Johnson ZK, Siddiqui MA, Azuara-Blanco A, et al. The quality 
of reporting of diagnostic accuracy studies of optical coherence 
tomography in glaucoma. Ophthalmology 2007;114:1607–12.
 47. Riveros C, Dechartres A, Perrodeau E, et al. Timing and 
completeness of trial results posted at  ClinicalTrials. gov and 
published in journals. PLoS Med 2013;10:e1001566.
 48. Hind D, Booth A. Do health technology assessments comply with 
QUOROM diagram guidance? An empirical study. BMC Med Res 
Methodol 2007;7:49.
 49. Lee PE, Fischer HD, Rochon PA, et al. Published randomized 
controlled trials of drug therapy for dementia often lack complete 
data on harm. J Clin Epidemiol 2008;61:1152–60.
 o
n
 10 M
ay 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026589 on 9 May 2019. Downloaded from 
11Blanco D, et al. BMJ Open 2019;9:e026589. doi:10.1136/bmjopen-2018-026589
Open access
 50. Pat K, Dooms C, Vansteenkiste J, et al. Systematic review of 
symptom control and quality of life in studies on chemotherapy for 
advanced non-small cell lung cancer: how CONSORTed are the 
data? Lung Cancer 2008;62:126–38.
 51. Folkes A, Urquhart R, Grunfeld E. Are leading medical journals 
following their own policies on CONSORT reporting? Contemp Clin 
Trials 2008;29:843–6.
 52. Sinha S, Sinha S, Ashby E, et al. Quality of reporting in randomized 
trials published in high-quality surgical journals. J Am Coll Surg 
2009;209:565–71.
 53. Freeman K, Szczepura A, Osipenko L, et al. Non-invasive fetal RHD 
genotyping tests: a systematic review of the quality of reporting 
of diagnostic accuracy in published studies. Eur J Obstet Gynecol 
Reprod Biol 2009;142:91–8.
 54. Uetani K, Nakayama T, Ikai H, et al. Quality of reports on 
randomized controlled trials conducted in Japan: evaluation 
of adherence to the CONSORT statement. Intern Med 
2009;48:307–13.
 55. Ethgen M, Boutron L, Steg PG, et al. Quality of reporting internal 
and external validity data from randomized controlled trials 
evaluating stents for percutaneous coronary intervention. BMC Med 
Res Methodol 2009;9:24.
 56. Krzych LJ, Liszka L. No improvement in studies reporting the 
diagnostic accuracy of B-type natriuretic peptide. Med Sci Monit 
2009;15:SR5–14.
 57. Pagoto SL, Kozak AT, John P, et al. Intention-to-treat analyses in 
behavioral medicine randomized clinical trials. Int J Behav Med 
2009;16:316–22.
 58. Kidwell CS, Liebeskind DS, Starkman S, et al. Trends in 
acute ischemic stroke trials through the 20th century. Stroke 
2001;32:1349–59.
 59. Han C, Kwak KP, Marks DM, et al. The impact of the CONSORT 
statement on reporting of randomized clinical trials in psychiatry. 
Contemp Clin Trials 2009;30:116–22.
 60. Alvarez F, Meyer N, Gourraud PA, et al. CONSORT adoption 
and quality of reporting of randomized controlled trials: a 
systematic analysis in two dermatology journals. Br J Dermatol 
2009;161:1159–65.
 61. Wei X, Tiejun L, Cheng W. Current situation on the reporting quality 
of randomized controlled trials in 5 leading Chinese medical 
journals. J Med Coll PLA 2009;24:105–11.
 62. Ladd BO, McCrady BS, Manuel JK, et al. Improving the quality 
of reporting alcohol outcome studies: effects of the CONSORT 
statement. Addict Behav 2010;35:660–6.
 63. Yu LM, Chan AW, Hopewell S, et al. Reporting on covariate 
adjustment in randomised controlled trials before and after 
revision of the 2001 CONSORT statement: a literature review. Trials 
2010;11:59.
 64. Areia M, Soares M, Dinis-Ribeiro M. Quality reporting of endoscopic 
diagnostic studies in gastrointestinal journals: where do we stand 
on the use of the STARD and CONSORT statements? Endoscopy 
2010;42:138–47.
 65. Delaney M, Meyer E, Cserti-Gazdewich C, et al. A systematic 
assessment of the quality of reporting for platelet transfusion 
studies. Transfusion 2010;50:2135–44.
 66. Flint HE, Harrison JE. How well do reports of clinical trials in the 
orthodontic literature comply with the CONSORT statement? J 
Orthod 2010;37:250–61.
 67. Hopewell S, Dutton S, Yu LM, et al. The quality of reports of 
randomised trials in 2000 and 2006: comparative study of articles 
indexed in PubMed. BMJ 2010;340:c723.
 68. Ernst E, Hung SK CY. NCCAM-funded RCTs of herbal medicines: 
An independent, critical assessment. Perfusion 2011;24:89–102 
https://www. researchgate. net/ publication/ 288438592_ NCCAM- 
funded_ RCTs_ of_ herbal_ medicines_ An_ independent_ critical_ 
assessment.
 69. Sánchez-Thorin JC, Cortés MC, Montenegro M, et al. The quality of 
reporting of randomized clinical trials published in Ophthalmology. 
Ophthalmology 2001;108:410–5.
 70. Selman TJ, Morris RK, Zamora J, et al. The quality of reporting 
of primary test accuracy studies in obstetrics and gynaecology: 
application of the STARD criteria. BMC Womens Health 2011;11:8.
 71. Parsons NR, Hiskens R, Price CL, et al. A systematic survey of the 
quality of research reporting in general orthopaedic journals. J Bone 
Joint Surg Br 2011;93:1154–9.
 72. Kiehna EN, Starke RM, Pouratian N, et al. Standards for reporting 
randomized controlled trials in neurosurgery. J Neurosurg 
2011;114:280–5.
 73. Strech D, Soltmann B, Weikert B, et al. Quality of reporting of 
randomized controlled trials of pharmacologic treatment of bipolar 
disorders: a systematic review. J Clin Psychiatry 2011;72:1214–21.
 74. Turner LA, Singh K, Garritty C, et al. An evaluation of the 
completeness of safety reporting in reports of complementary 
and alternative medicine trials. BMC Complement Altern Med 
2011;11:67.
 75. Haidich AB, Birtsou C, Dardavessis T, et al. The quality of safety 
reporting in trials is still suboptimal: survey of major general medical 
journals. J Clin Epidemiol 2011;64:124–35.
 76. Gray R, Sullivan M, Altman DG, et al. Adherence of trials of 
operative intervention to the CONSORT statement extension for 
non-pharmacological treatments: a comparative before and after 
study. Ann R Coll Surg Engl 2012;94:388–94.
 77. Cornelius VR, Sauzet O, Williams JE, et al. Adverse event reporting 
in randomised controlled trials of neuropathic pain: considerations 
for future practice. Pain 2013;154:213–20.
 78. Diaz-Ordaz K, Froud R, Sheehan B, et al. A systematic review of 
cluster randomised trials in residential facilities for older people 
suggests how to improve quality. BMC Med Res Methodol 
2013;13:127.
 79. Geha NN, Moseley AM, Elkins MR, et al. The quality and reporting 
of randomized trials in cardiothoracic physical therapy could be 
substantially improved. Respir Care 2013;58:1899–906.
 80. Moher D, Jones A, Lepage L. CONSORT Group (Consolidated 
Standards for Reporting of Trials). Use of the CONSORT statement 
and quality of reports of randomized trials: a comparative before-
and-after evaluation. JAMA 2001;285:1992–5.
 81. Liu LQ, Morris PJ, Pengel LH, et al. Compliance to the CONSORT 
statement of randomized controlled trials in solid organ 
transplantation: a 3-year overview. Transpl Int 2013;26:300–6.
 82. Panic N, Leoncini E, de Belvis G, et al. Evaluation of the 
endorsement of the preferred reporting items for systematic reviews 
and meta-analysis (PRISMA) statement on the quality of published 
systematic review and meta-analyses. PLoS One 2013;8:e83138.
 83. Fleming PS, Seehra J, Polychronopoulou A, et al. A PRISMA 
assessment of the reporting quality of systematic reviews in 
orthodontics. Angle Orthod 2013;83:158–63.
 84. Péron J, Maillet D, Gan HK, et al. Adherence to CONSORT adverse 
event reporting guidelines in randomized clinical trials evaluating 
systemic cancer therapy: a systematic review. J Clin Oncol 
2013;31:3957–63.
 85. Tunis AS, McInnes MD, Hanna R, et al. Association of study quality 
with completeness of reporting: have completeness of reporting 
and quality of systematic reviews and meta-analyses in major 
radiology journals changed since publication of the PRISMA 
statement? Radiology 2013;269:413–26.
 86. Maclean EN, Stone IS, Ceelen F, et al. Reporting standards in 
cardiac MRI, CT, and SPECT diagnostic accuracy studies: analysis 
of the impact of STARD criteria. Eur Heart J Cardiovasc Imaging 
2014;15:691–700.
 87. Baker D, Lidster K, Sottomayor A, et al. Two years later: journals are 
not yet enforcing the ARRIVE guidelines on reporting standards for 
pre-clinical animal studies. PLoS Biol 2014;12:e1001756.
 88. Choi J, Jun JH, Kang BK, et al. Endorsement for improving the 
quality of reports on randomized controlled trials of traditional 
medicine journals in Korea: a systematic review. Trials 2014;15:429.
 89. Walther S, Schueler S, Tackmann R, et al. Compliance with STARD 
checklist among studies of coronary CT angiography: systematic 
review. Radiology 2014;271:74–86.
 90. Ghimire S, Kyung E, Lee H, et al. Oncology trial abstracts showed 
suboptimal improvement in reporting: a comparative before-and-
after evaluation using CONSORT for Abstract guidelines. J Clin 
Epidemiol 2014;67:658–66.
 91. Devereaux PJ, Manns BJ, Ghali WA, et al. The reporting of 
methodological factors in randomized controlled trials and the 
association with a journal policy to promote adherence to the 
Consolidated Standards of Reporting Trials (CONSORT) checklist. 
Control Clin Trials 2002;23:380–8.
 92. Song TJ, Leng HF, Zhong LL, et al. CONSORT in China: past 
development and future direction. Trials 2015;16:243.
 93. Stevely A, Dimairo M, Todd S, et al. An Investigation of the 
Shortcomings of the CONSORT 2010 Statement for the 
Reporting of Group Sequential Randomised Controlled Trials: A 
Methodological Systematic Review. PLoS One 2015;10:e0141104.
 94. Adie S, Ma D, Harris IA, et al. Quality of conduct and reporting of 
meta-analyses of surgical interventions. Ann Surg 2015;261:685–94.
 95. Jull A, Aye PS. Endorsement of the CONSORT guidelines, trial 
registration, and the quality of reporting randomised controlled trials 
in leading nursing journals: A cross-sectional analysis. Int J Nurs 
Stud 2015;52:1071–9.
 96. Bearn DR, Alharbi F. Reporting of clinical trials in the orthodontic 
literature from 2008 to 2012: observational study of published 
reports in four major journals. J Orthod 2015;42:186–91.
 o
n
 10 M
ay 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026589 on 9 May 2019. Downloaded from 
12 Blanco D, et al. BMJ Open 2019;9:e026589. doi:10.1136/bmjopen-2018-026589
Open access 
 97. Agha RA, Fowler AJ, Limb C, et al. Impact of the mandatory 
implementation of reporting guidelines on reporting quality 
in a surgical journal: A before and after study. Int J Surg 
2016;30:169–72.
 98. Pouwels KB, Widyakusuma NN, Groenwold RH, et al. Quality of 
reporting of confounding remained suboptimal after the STROBE 
guideline. J Clin Epidemiol 2016;69:217–24.
 99. Rao A, Brück K, Methven S, et al. Quality of reporting and 
study design of ckd cohort studies assessing mortality in the 
elderly before and after strobe: A systematic review. PLoS One 
2016;11:e0155078.
 100. Grob ATM, van der Vaart LR, Withagen MIJ, et al. Quality of 
reporting of diagnostic accuracy studies on pelvic floor three-
dimensional transperineal ultrasound: a systematic review. 
Ultrasound Obstet Gynecol 2017;50:451–7.
 101. Rikos D, Dardiotis E, Tsivgoulis G, et al. Reporting quality of 
randomized-controlled trials in multiple sclerosis from 2000 to 
2015, based on CONSORT statement. Mult Scler Relat Disord 
2016;9:135–9.
 102. Montori VM, Bhandari M, Devereaux PJ, et al. In the dark: the 
reporting of blinding status in randomized controlled trials. J Clin 
Epidemiol 2002;55:787–90.
 103. Bigna JJ, Um LN, Nansseu JR. A comparison of quality of 
abstracts of systematic reviews including meta-analysis of 
randomized controlled trials in high-impact general medicine 
journals before and after the publication of PRISMA extension 
for abstracts: a systematic review and meta-analysis. Syst Rev 
2016;5:174.
 104. Sarkis-Onofre R, Poletto-Neto V, Cenci MS, et al. Impact of the 
CONSORT Statement endorsement in the completeness of 
reporting of randomized clinical trials in restorative dentistry. J Dent 
2017;58:54–9.
 105. Tharyan P, Premkumar TS, Mathew V, et al. Editorial policy and the 
reporting of randomized controlled trials: a survey of instructions for 
authors and assessment of trial reports in Indian medical journals 
(2004-05). Natl Med J India 2008;21:62–8.
 106. Lai TY, Wong VW, Lam RF, et al. Quality of reporting of key 
methodological items of randomized controlled trials in clinical 
ophthalmic journals. Ophthalmic Epidemiol 2007;14:390–8.
 107. Cobo E, Selva-O'Callagham A, Ribera JM, et al. Statistical 
reviewers improve reporting in biomedical articles: a randomized 
trial. PLoS One 2007;2:e332.
 108. Implementing Reporting Guidelines: Why and How, for Journal 
Editors [Internet]. World Association of Medical Editors. https:// 
wame. blog/ 2017/ 09/ 17/ implementing- reporting- guidelines- why- 
and- how- for- journal- editors/.
 109. Rupinski M, Zagorowicz E, Regula J, et al. Randomized comparison 
of three palliative regimens including brachytherapy, photodynamic 
therapy, and APC in patients with malignant dysphagia (CONSORT 
1a) (Revised II). Am J Gastroenterol 2011;106:1612–20.
 110. Jilka RL. The Road to Reproducibility in Animal Research. J Bone 
Miner Res 2016;31:1317–9.
 111. Moher D, Altman DG. Four Proposals to Help Improve the Medical 
Research Literature. PLoS Med 2015;12:e1001864.
 112. Pandis N, Turpin DL. Enhancing CONSORT compliance for 
improved reporting of randomized controlled trials. Am J Orthod 
Dentofacial Orthop 2014;145:1.
 113. Hill CL, LaValley MP, Felson DT. Secular changes in the quality of 
published randomized clinical trials in rheumatology. Arthritis & 
Rheumatism 2002;46:779–84.
 114. Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension 
statement for reporting of systematic reviews incorporating 
network meta-analyses of health care interventions: checklist and 
explanations. Ann Intern Med 2015;162:777–84.
 115. Hirst A, Altman DG. Are peer reviewers encouraged to use reporting 
guidelines? A survey of 116 health research journals. PLoS One 
2012;7:e35621.
 116.  ClinicalTrials. gov. National Library of Medicine (US). https:// 
clinicaltrials. gov/.
 117. Pandis N, Shamseer L, Kokich VG, et al. Active implementation 
strategy of CONSORT adherence by a dental specialty journal 
improved randomized clinical trial reporting. J Clin Epidemiol 
2014;67:1044–8.
 118. Cobo E, Cortes J, Ribera JM, et al. Effect of using reporting 
guidelines during peer review on quality of final manuscripts 
submitted to a biomedical journal: masked randomised trial. BMJ 
2011;343:d6783.
 119. Hopewell S, Boutron I, Altman DG, et al. Impact of a web-based 
tool (WebCONSORT) to improve the reporting of randomised trials: 
results of a randomised controlled trial. BMC Med 2016;14:199.
 120. Hopewell S, Collins GS, Boutron I, et al. Impact of peer review on 
reports of randomised trials published in open peer review journals: 
retrospective before and after study. BMJ 2014;349:g4145.
 121. A peerless review?. Automating methodological and statistical 
review. https:// blogs. biomedcentral. com/ bmcblog/ 2016/ 05/ 23/ 
peerless- review- automating- methodological- statistical- review/.
 122. Mbuagbaw L, Thabane M, Vanniyasingam T, et al. Improvement in 
the quality of abstracts in major clinical journals since CONSORT 
extension for abstracts: a systematic review. Contemp Clin Trials 
2014;38:245–50.
 123. Schriger DL, Altman DG. Inadequate post-publication review of 
medical research. BMJ 2010;341:c3803.
 124. Statreviewer.Available from: http://www. statreviewer. com/
 125. Tools and templates for implementing reporting guidelines. http://
www. equator- network. org/ toolkits/ using- guidelines- in- journals/ 
tools- and- templates- for- implementing- reporting- guidelines/.
 126. PubPeer. Available from: https:// pubpeer. com/
 127. ScienceOpen. Available from: https://www. scienceopen. com/
 128. Péron J, You B, Gan HK, et al. Influence of statistician involvement 
on reporting of randomized clinical trials in medical oncology. 
Anticancer Drugs 2013;24:306–9.
 129. Pandis N, Polychronopoulou A, Eliades T. An assessment of quality 
characteristics of randomised control trials published in dental 
journals. J Dent 2010;38:713–21.
 130. Kloukos D, Papageorgiou SN, Doulis I, et al. Reporting quality 
of randomised controlled trials published in prosthodontic and 
implantology journals. J Oral Rehabil 2015;42:914–25.
 131. Blanco D, Biggane AM, Cobo E. MiRoR network. Are CONSORT 
checklists submitted by authors adequately reflecting what 
information is actually reported in published papers?. Trials 
2018;19:80.
 132. Koletsi D, Fleming PS, Behrents RG, et al. The use of tailored 
subheadings was successful in enhancing compliance with 
CONSORT in a dental journal. J Dent 2017;67:66–71.
 133. Cobo E, González JA. Taking advantage of unexpected 
WebCONSORT results. BMC Med 2016;14:204.
 134. Tijdink JK, Schipper K, Bouter LM, et al. How do scientists 
perceive the current publication culture? A qualitative focus group 
interview study among Dutch biomedical researchers. BMJ Open 
2016;6:e008681.
 o
n
 10 M
ay 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-026589 on 9 May 2019. Downloaded from 
